Literature DB >> 27040033

Symptomatic, Magnetic Resonance Imaging-Confirmed Cervical Disk Herniation Patients: A Comparative-Effectiveness Prospective Observational Study of 2 Age- and Sex-Matched Cohorts Treated With Either Imaging-Guided Indirect Cervical Nerve Root Injections or Spinal Manipulative Therapy.

Cynthia K Peterson1, Christian W A Pfirrmann2, Jürg Hodler3, Serafin Leemann4, Christof Schmid4, Bernard Anklin4, B Kim Humphreys5.   

Abstract

OBJECTIVE: The purpose of this study was to compare the outcomes of overall improvement, pain reduction, and treatment costs in matched patients with symptomatic, magnetic resonance imaging-confirmed cervical disk herniations treated with either spinal manipulative therapy (SMT) or imaging-guided cervical nerve root injection blocks (CNRI).
METHODS: This prospective cohort comparative-effectiveness study included 104 patients with magnetic resonance imaging-confirmed symptomatic cervical disk herniation. Fifty-two patients treated with CNRI were age and sex matched with 52 patients treated with SMT. Baseline numerical rating scale (NRS) pain data were collected. Three months after treatment, NRS pain levels were recorded and overall "improvement" was assessed using the Patient Global Impression of Change scale. Only responses "much better" or "better" were considered "improved." The proportion of patients "improved" was calculated for each treatment method and compared using the χ(2) test. The NRS and NRS change scores for the 2 groups were compared at baseline and 3 months using the unpaired t test. Acute and subacute/chronic patients in the 2 groups were compared for "improvement" using the χ(2) test.
RESULTS: "Improvement" was reported in 86.5% of SMT patients and 49.0% of CNRI patients (P = .0001). Significantly more CNRI patients were in the subacute/chronic category (77%) compared with SMT patients (46%). A significant difference between the proportion of subacute/chronic CNRI patients (37.5%) and SMT patients (78.3%) reporting "improvement" was noted (P = .002).
CONCLUSION: Subacute/chronic patients treated with SMT were significantly more likely to report relevant "improvement" compared with CNRI patients. There was no difference in outcomes when comparing acute patients only.
Copyright © 2016 National University of Health Sciences. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical Spine; Comparative-Effectiveness Research; Disk Herniation; Injections; Manipulation, Spinal; Nerve Root; Outcomes Assessment; Radiculopathy

Mesh:

Year:  2016        PMID: 27040033     DOI: 10.1016/j.jmpt.2016.02.004

Source DB:  PubMed          Journal:  J Manipulative Physiol Ther        ISSN: 0161-4754            Impact factor:   1.437


  5 in total

1.  Successful outcomes following transforaminal epidural steroid injections for C4/5 cervical disc prolapse associated with profound neurological deficit.

Authors:  Adam Meir; Keith Bush
Journal:  Eur Spine J       Date:  2017-03-27       Impact factor: 3.134

2.  Effectiveness of Multimodal Rehabilitation Interventions for Management of Cervical Radiculopathy in Adults: An Updated Systematic Review from the Ontario Protocol for Traffic Injury Management (Optima) Collaboration.

Authors:  Fabrice Mallard; Jessica J Wong; Nadège Lemeunier; Pierre Côté
Journal:  J Rehabil Med       Date:  2022-08-22       Impact factor: 3.959

Review 3.  Outcomes indicators and a risk classification system for spinal manipulation under anesthesia: a narrative review and proposal.

Authors:  Dennis DiGiorgi; John L Cerf; Daniel S Bowerman
Journal:  Chiropr Man Therap       Date:  2018-03-08

4.  Spinal manipulation and therapeutic exercises in treating post-surgical resurgent lumbar radiculopathy.

Authors:  Vinicius Tieppo Francio; Chris Towery; Saeid Davani; Tony Brown
Journal:  Oxf Med Case Reports       Date:  2017-10-13

5.  Biomechanical Effects of Lateral Bending Position on Performing Cervical Spinal Manipulation for Cervical Disc Herniation: A Three-Dimensional Finite Element Analysis.

Authors:  Xuecheng Huang; Linqiang Ye; Zixian Wu; Lichang Liang; Qianli Wang; Weibo Yu; Xiaobing Jiang
Journal:  Evid Based Complement Alternat Med       Date:  2018-06-11       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.